← Back to Search

Educational Program for Breast Cancer Survivors

N/A

Recruiting

Led By Erica Warner, MPH, ScD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial tests a 6-week online course to help Black breast cancer survivors with physical activity, goal setting, nutrition, sleep, stress, and social connections.

Who is the study for?

This trial is for Black or African American women aged 22-79 who have been diagnosed with Stage I, II, or III invasive breast cancer. Participants must have completed active treatment at least 6 months ago but within the last five years and speak English.Check my eligibility

What is being tested?

The study is testing a virtual education program tailored for Black breast cancer survivors. Over six weeks, it covers topics like physical activity, nutrition, goal setting, sleep management, stress reduction, and building social connections.See study design

What are the potential side effects?

Since this is an educational intervention focusing on lifestyle improvements and support rather than medical treatments or drugs, there are no direct side effects associated with typical clinical trials.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Data collection feasibility

Proportion of Eligible Participants

Rate of Intervention Completion

+3 more

Secondary outcome measures

Dietary Behavior Goal Change

Intention to Receive post-treatment Surveillance Mammography

Physical Activity Goal Change

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Breast Cancer Survivor Education ProgramExperimental Treatment1 Intervention

Participants will complete study procedures as outlined: - 6 weekly sessions of a modified version of the PAVING the Path to Wellness education program.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

PfizerIndustry Sponsor

4,567 Previous Clinical Trials

10,911,858 Total Patients Enrolled

110 Trials studying Breast Cancer

36,389 Patients Enrolled for Breast Cancer

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,340 Total Patients Enrolled

80 Trials studying Breast Cancer

132,897 Patients Enrolled for Breast Cancer

American Cancer Society, Inc.OTHER

224 Previous Clinical Trials

110,440 Total Patients Enrolled

32 Trials studying Breast Cancer

8,869 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies that participants can join in this clinical research?

"Data hosted on clinicaltrials.gov affirms that enrollment for this particular trial was closed as of January 17th 2023 and is no longer accepting patients at the moment. Despite this, there are currently over 2500 other studies actively recruiting participants."

Answered by AI

What purposes does this trial seek to achieve?

"According to the Pfizer-sponsored trial, their primary endpoint is Time Required to Recruit to Target and will be monitored over a 6 week period. Additionally, secondary outcomes being observed include Intention to Receive post-treatment Surveillance Mammography (via FOCUS Survey), Physical Activity Goal Change (also via FOCUS Survey) and Dietary Behavior Goal Change (again with the help of the FOCUS survey)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Breast Cancer Survivor Educational Intervention

Erica T. Warner, ScD MPH 2023. "Breast Cancer Survivor Educational Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05700396.